Jessica Kapustin, Senior Director, Precision Medicine Marketing at AstraZeneca, shared on LinkedIn:
“This post is intended for U.S. audiences.
During Lung Cancer Awareness Month, Biomarker Awareness Day is an important opportunity to recognize how precision medicine is helping us better understand the unique characteristics of each person’s cancer.
Biomarker testing can uncover important information about a person’s tumor that may help inform treatment decisions and more personalized care. But realizing the potential of precision medicine also means helping patients understand why testing matters and empowering them to have informed conversations with their care teams.
That’s why AstraZeneca launched Meet Your Mark, a consumer education campaign designed to make biomarker testing easier to understand and encourage people facing lung and other cancers, to ask their doctors whether testing may be right for them.
This Biomarker Awareness Day, I’m proud of the work we’re doing to help translate the science of precision medicine into information patients can understand and act on.
Learn more about biomarker testing.”
You may also be interested in:
Highlighting Global Research Efforts for Lung Cancer Awareness Month 2026 – IARC
BTOG to Champion Education, Collaboration, and Research During Lung Cancer Awareness Month